LI
KIN

Leap Investments’s Kindred Biosciences, Inc. KIN Stock Holding History

Leap Investments’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$64K Buy
+14,300
New +$63.9K 0.04% 372

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Leap Investments's KIN Position: Q2 2020 in Review

Leap Investments opened a new position in Kindred Biosciences, Inc. (KIN) in Q2 2020: 14,300 shares worth $64K. The stake represents 0.04% of the portfolio and ranks #372 among its holdings.

83 funds tracked by Wall St. Rank hold KIN as of Q2 2020.

  • Leap Investments held 14,300 shares of Kindred Biosciences, Inc. worth $64K as of Q2 2020.
  • Kindred Biosciences, Inc. was a new Leap Investments position in Q2 2020.
  • Kindred Biosciences, Inc. made up 0.04% of Leap Investments's portfolio in Q2 2020, its #372 holding.
  • 83 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.